HOME Research Insight Key Players in the Tissue Diagnostics Market Focus on Product Launches and Partnerships



Key Players in the Tissue Diagnostics Market Focus on Product Launches and Partnerships


The tissue diagnostics market is expected to reach USD 5.14 Billion by 2022 from USD 3.68 Billion in 2017, at a CAGR of 6.9%. Factors driving the growth of this market include the rising incidence of cancer, growing healthcare expenditure, improving infrastructure for cancer diagnosis, and technological advancements in tissue diagnostics.

The tissue diagnostics market is consolidated in nature due to the presence of a large number of players. The key players in the market are Roche (Switzerland), Danaher (US), Thermo Fisher Scientific (US), Abbott (US), Agilent Technologies (US), Merck (Germany), Sakura Finetek Japan (Japan), Abcam (UK), BD (US), QIAGEN (Netherlands), Sienna Cancer Diagnostics (Australia), Royal Philips (Netherlands), A. Menarini Diagnostics (Italy), Cell Signaling Technology (US), Enzo Life Sciences (US), Master Diagnóstica (Spain), TissueGnostics (Austria), Bio SB (US), MedImmune (US), Cernostics (US), Zenalux Biomedical (US), 3DHISTECH (Hungary), Lunaphore Technologies (Switzerland), BioGenex (US), and Biocare Medical (US).

The key strategy followed by most companies in the tissue diagnostics market are product launches and partnerships. These strategies accounted for the largest share of the overall growth strategies mapped from 2015 to 2017. Some of the leading players who adopted this strategy include Roche (Switzerland), Danaher (US), Thermo Fisher Scientific (US), Agilent Technologies (US), and Abbott (US).

Roche (Switzerland) accounted for the largest share of the tissue diagnostics market in 2016. The company has a wide range of products, covering all major technologies of tissue diagnostics. Roche differentiates its products via branding. Product innovation is one of the key goals of the company and the company launched a number of innovative products over the last three years. For example, in 2015, the company introduced VENTANA HE 600 system, which is a new automated hematoxylin and eosin (H&E) tissue staining system with customizable protocols.

Danaher (US) accounted for the second-largest market share of the tissue diagnostics market in 2016. The company has a broad product portfolio and has launched innovative products to enable the rapid and accurate diagnosis from tissue samples. The company focuses on growing inorganically as it partnered with various companies over the last three years to strengthen its position in the market. In 2017, the company partnered with Advanced Cell Diagnostics (US) to develop and commercialize innovative tissue diagnostic instruments.

Related Reports:

Tissue Diagnostics Market by Product (Consumables, Instruments), Technology (Immunohistochemistry, in Situ Hybridization, Digital Pathology & Workflow), Disease (Breast Cancer, Gastric Cancer, Lymphoma), End User (Hospital, CRO) - Global Forecast to 2022

Contact:
Mr. Rohan
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports